Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Myron Levin

Concepts (855)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Herpes Zoster
106
2025
318
17.740
 Why?
Herpes Zoster Vaccine
66
2025
154
16.270
 Why?
Herpesvirus 3, Human
87
2025
341
11.910
 Why?
Antibodies, Viral
67
2026
673
4.960
 Why?
Chickenpox
24
2023
82
4.900
 Why?
Immunity, Cellular
36
2024
273
4.450
 Why?
Chickenpox Vaccine
27
2023
75
3.690
 Why?
Influenza Vaccines
18
2024
533
2.810
 Why?
Vaccines, Attenuated
32
2024
129
2.600
 Why?
HIV Infections
39
2026
3189
2.350
 Why?
Neuralgia, Postherpetic
18
2019
40
2.330
 Why?
Immunocompromised Host
13
2019
202
2.310
 Why?
Antiviral Agents
28
2022
772
2.190
 Why?
Adjuvants, Immunologic
17
2023
246
2.030
 Why?
Simplexvirus
24
2016
82
2.020
 Why?
Acyclovir
27
2016
97
1.960
 Why?
Herpes Simplex
17
2016
98
1.800
 Why?
Vaccination
33
2023
1423
1.770
 Why?
DNA, Viral
24
2018
357
1.660
 Why?
Trypanosoma cruzi
13
2007
39
1.620
 Why?
Papillomavirus Vaccines
13
2018
296
1.490
 Why?
Viral Envelope Proteins
6
2021
98
1.400
 Why?
Herpesvirus 1, Human
10
2016
84
1.380
 Why?
Vaccines, Synthetic
16
2025
138
1.340
 Why?
Influenza, Human
13
2024
623
1.340
 Why?
Pregnancy Complications, Infectious
16
2020
437
1.330
 Why?
T-Lymphocytes
20
2019
1996
1.310
 Why?
Humans
296
2026
145491
1.300
 Why?
Antiretroviral Therapy, Highly Active
13
2017
279
1.270
 Why?
Immunologic Memory
12
2019
368
1.230
 Why?
Aged
92
2024
26125
1.220
 Why?
Aged, 80 and over
47
2022
8326
1.200
 Why?
Immunization, Secondary
13
2017
92
1.200
 Why?
CD4-Positive T-Lymphocytes
13
2023
1138
1.160
 Why?
Papillomavirus Infections
9
2018
343
1.110
 Why?
Antibodies, Protozoan
5
2007
41
1.100
 Why?
Middle Aged
102
2026
36176
1.030
 Why?
Ribosomal Proteins
6
2006
94
1.010
 Why?
Chagas Disease
8
2007
42
0.990
 Why?
Double-Blind Method
33
2026
2060
0.990
 Why?
Pneumococcal Vaccines
4
2026
129
0.980
 Why?
Female
158
2026
78763
0.960
 Why?
Protozoan Proteins
6
2006
94
0.960
 Why?
Male
141
2026
72817
0.920
 Why?
T-Lymphocyte Subsets
6
2019
418
0.920
 Why?
Vaccines, Inactivated
9
2023
70
0.860
 Why?
Receptors, Adrenergic, beta-1
4
2007
24
0.850
 Why?
Viral Vaccines
12
2014
108
0.850
 Why?
Antibodies, Neutralizing
13
2023
342
0.840
 Why?
Incidence
22
2023
2915
0.820
 Why?
Herpesvirus 2, Human
6
2014
27
0.820
 Why?
Interferon-gamma
18
2022
782
0.790
 Why?
Virus Latency
4
2014
90
0.790
 Why?
Immune Sera
4
2020
77
0.770
 Why?
Respiratory Syncytial Virus, Human
3
2019
81
0.770
 Why?
CD8-Positive T-Lymphocytes
5
2018
917
0.760
 Why?
B-Lymphocytes
9
2021
878
0.750
 Why?
Enzyme-Linked Immunosorbent Assay
22
2021
839
0.750
 Why?
Injections, Intramuscular
5
2022
147
0.740
 Why?
Influenza A Virus, H1N1 Subtype
6
2017
158
0.710
 Why?
Age Factors
17
2021
3340
0.700
 Why?
Respiratory Syncytial Virus Vaccines
2
2019
39
0.700
 Why?
Rotavirus Infections
3
2017
37
0.690
 Why?
Drug Resistance, Viral
7
2009
124
0.690
 Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
6
2017
13
0.680
 Why?
Influenza B virus
6
2012
47
0.650
 Why?
Anti-Retroviral Agents
5
2018
251
0.640
 Why?
Vaccination Coverage
2
2018
102
0.630
 Why?
Rotavirus Vaccines
2
2017
39
0.620
 Why?
Adenovirus Infections, Human
4
2015
15
0.610
 Why?
Infectious Disease Transmission, Vertical
7
2020
194
0.600
 Why?
Down Syndrome
2
2023
525
0.590
 Why?
Adult
77
2026
40707
0.590
 Why?
Th1 Cells
3
2018
139
0.580
 Why?
Polymerase Chain Reaction
13
2019
1049
0.580
 Why?
Clinical Trials as Topic
15
2019
1058
0.580
 Why?
Child, Preschool
43
2026
11837
0.570
 Why?
Insurance Claim Review
1
2019
83
0.560
 Why?
HIV
4
2010
252
0.560
 Why?
AIDS-Related Opportunistic Infections
4
2015
130
0.550
 Why?
Alphapapillomavirus
4
2016
35
0.550
 Why?
Influenza A Virus, H3N2 Subtype
4
2017
50
0.550
 Why?
Cytomegalovirus Infections
4
2015
206
0.550
 Why?
CD4 Lymphocyte Count
14
2017
280
0.550
 Why?
Antibody Formation
8
2023
291
0.540
 Why?
Immunoglobulin G
11
2021
890
0.530
 Why?
Child
60
2026
22680
0.530
 Why?
Dose-Response Relationship, Immunologic
3
2016
76
0.530
 Why?
Virus Shedding
6
2017
48
0.520
 Why?
Infant
31
2023
10064
0.520
 Why?
Pneumonia
1
2023
632
0.510
 Why?
Health Expenditures
1
2019
194
0.510
 Why?
Adolescent
54
2026
22485
0.500
 Why?
Interleukin-2
7
2022
440
0.500
 Why?
Herpesviridae Infections
4
2015
149
0.500
 Why?
Cytosine
3
2015
49
0.500
 Why?
Pain
6
2022
787
0.500
 Why?
Anti-HIV Agents
6
2015
908
0.490
 Why?
Infant, Premature
5
2020
619
0.480
 Why?
Antigens, Viral
21
2017
182
0.480
 Why?
Organophosphonates
2
2015
97
0.480
 Why?
Cytomegalovirus
7
2006
168
0.460
 Why?
Injections, Subcutaneous
1
2016
170
0.460
 Why?
Guanine
14
2006
85
0.450
 Why?
Enzyme-Linked Immunospot Assay
4
2018
37
0.450
 Why?
Follow-Up Studies
22
2019
5426
0.450
 Why?
Refrigeration
2
2018
12
0.440
 Why?
Immunization
5
2014
375
0.440
 Why?
Polyomavirus Infections
1
2015
30
0.440
 Why?
Health Care Costs
1
2018
427
0.430
 Why?
Immunity, Humoral
3
2021
120
0.430
 Why?
Uterine Cervical Neoplasms
5
2016
269
0.420
 Why?
Viral Load
12
2018
528
0.420
 Why?
Skin Diseases
1
2016
152
0.420
 Why?
Oropharynx
1
2014
46
0.420
 Why?
Herpes Genitalis
7
2014
17
0.420
 Why?
Blood
1
2014
107
0.410
 Why?
Drug Combinations
4
2023
397
0.400
 Why?
Infant, Newborn
28
2023
6437
0.390
 Why?
Monocytes
8
2025
536
0.390
 Why?
Immunogenicity, Vaccine
4
2022
36
0.390
 Why?
Vaccines
3
2018
388
0.390
 Why?
Herpes Labialis
3
2013
8
0.380
 Why?
T-Lymphocytes, Regulatory
1
2016
407
0.380
 Why?
Placebos
8
2017
193
0.380
 Why?
Trigeminal Ganglion
2
2003
27
0.370
 Why?
Time Factors
20
2021
7171
0.370
 Why?
Post-Exposure Prophylaxis
2
2023
13
0.350
 Why?
Aging
10
2017
1940
0.350
 Why?
Sensory Receptor Cells
1
2012
98
0.350
 Why?
United States
18
2026
16115
0.350
 Why?
RNA, Viral
21
2018
693
0.340
 Why?
Young Adult
24
2023
14192
0.340
 Why?
Retrospective Studies
16
2023
17269
0.340
 Why?
Communicable Diseases
1
2014
166
0.340
 Why?
Randomized Controlled Trials as Topic
8
2021
1755
0.340
 Why?
Human papillomavirus 18
5
2018
12
0.310
 Why?
Quality of Life
7
2021
3195
0.310
 Why?
Human papillomavirus 16
5
2018
27
0.310
 Why?
Glycoproteins
2
2023
353
0.310
 Why?
Pregnancy
20
2020
7197
0.310
 Why?
Databases, Factual
4
2019
1500
0.300
 Why?
Animals
42
2021
38141
0.300
 Why?
Induced Pluripotent Stem Cells
1
2012
272
0.300
 Why?
Chagas Cardiomyopathy
4
2007
27
0.300
 Why?
Poverty
1
2013
525
0.290
 Why?
Cost-Benefit Analysis
4
2024
645
0.290
 Why?
Frail Elderly
2
2020
136
0.290
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2009
20
0.290
 Why?
Vaccines, Subunit
5
2021
53
0.290
 Why?
Risk Factors
20
2023
10874
0.280
 Why?
Treatment Outcome
19
2016
11831
0.270
 Why?
Epitopes
4
2005
480
0.270
 Why?
Varicella Zoster Virus Infection
2
2018
28
0.270
 Why?
Meningitis, Viral
3
1997
20
0.260
 Why?
Activities of Daily Living
3
2021
441
0.260
 Why?
Meningitis
1
2008
80
0.260
 Why?
Hemagglutination Inhibition Tests
7
2017
38
0.260
 Why?
Research Design
2
2013
1134
0.250
 Why?
Seasons
3
2023
559
0.250
 Why?
Cytokines
7
2018
2054
0.250
 Why?
Autoantibodies
3
2007
1512
0.250
 Why?
Viral Plaque Assay
8
2012
29
0.250
 Why?
Cells, Cultured
19
2012
4127
0.250
 Why?
Antibodies, Monoclonal
3
2023
1511
0.250
 Why?
Recurrence
14
2019
1142
0.250
 Why?
Viremia
5
2018
160
0.250
 Why?
Prospective Studies
25
2019
8039
0.240
 Why?
Neurons
6
2003
1647
0.240
 Why?
Immunocompetence
4
2019
46
0.230
 Why?
Respiratory Syncytial Virus Infections
3
2017
139
0.230
 Why?
Nucleic Acid Hybridization
11
2006
186
0.230
 Why?
Drug-Related Side Effects and Adverse Reactions
4
2017
261
0.220
 Why?
Neoplasms
3
2016
2897
0.220
 Why?
Virus Replication
12
2018
527
0.220
 Why?
Cell Count
2
2005
320
0.220
 Why?
Cross Reactions
6
2014
130
0.220
 Why?
Nucleosides
1
2004
25
0.220
 Why?
Sleep Wake Disorders
4
2013
310
0.220
 Why?
Intestines
2
2018
357
0.220
 Why?
Severity of Illness Index
14
2015
2945
0.210
 Why?
Vaccine Potency
3
2019
6
0.210
 Why?
Transforming Growth Factor beta1
1
2025
176
0.210
 Why?
Viral Proteins
5
2018
353
0.210
 Why?
Molecular Sequence Data
9
2006
2910
0.210
 Why?
Influenza A virus
5
2012
117
0.210
 Why?
Health Resources
2
2019
130
0.210
 Why?
Nonlinear Dynamics
1
2005
96
0.210
 Why?
Interferons
9
1982
186
0.200
 Why?
Phosphoproteins
1
2006
339
0.200
 Why?
Herpesvirus 4, Human
3
2014
177
0.200
 Why?
Cholecalciferol
1
2024
61
0.200
 Why?
Genetic Variation
1
2008
988
0.200
 Why?
Neuralgia
4
2010
148
0.200
 Why?
Immunoassay
2
2017
108
0.190
 Why?
Antibody Affinity
2
2021
60
0.190
 Why?
Long-Term Care
1
2024
117
0.190
 Why?
Enterovirus Infections
5
1995
173
0.190
 Why?
Cricetinae
6
2007
299
0.190
 Why?
Transforming Growth Factor beta
1
2025
475
0.190
 Why?
Encephalitis
2
1995
142
0.190
 Why?
Ganglia, Spinal
2
1993
89
0.180
 Why?
CHO Cells
3
2007
166
0.180
 Why?
Developing Countries
2
2016
317
0.180
 Why?
Pain Measurement
8
2019
558
0.180
 Why?
Lymphocyte Activation
13
2015
1134
0.180
 Why?
Papillomaviridae
3
2011
116
0.180
 Why?
Antibodies, Bacterial
4
2026
147
0.180
 Why?
Recombinant Proteins
4
2018
1367
0.180
 Why?
Lymphocytosis
1
2021
11
0.180
 Why?
Virus Activation
4
2010
95
0.180
 Why?
Longitudinal Studies
8
2018
2950
0.170
 Why?
Immunosenescence
1
2021
5
0.170
 Why?
Mice
12
2021
18338
0.170
 Why?
Cell Separation
1
2002
304
0.170
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
76
0.170
 Why?
Herpes Simplex Virus Vaccines
2
2012
4
0.170
 Why?
Genes, Protozoan
1
2000
13
0.170
 Why?
Virology
1
2001
36
0.160
 Why?
Fluorescent Antibody Technique
6
2016
364
0.160
 Why?
Cell Line
16
2018
2823
0.160
 Why?
Intermediate Filament Proteins
1
2000
57
0.160
 Why?
Case-Control Studies
5
2018
3619
0.160
 Why?
Fetal Diseases
4
1991
194
0.160
 Why?
Amino Acid Sequence
5
2006
2137
0.160
 Why?
RNA Helicases
1
2000
31
0.160
 Why?
Fibroblasts
10
2018
1023
0.160
 Why?
Vitamin D
1
2024
403
0.160
 Why?
Immunoglobulin A
3
2017
214
0.160
 Why?
Terminal Repeat Sequences
1
2000
17
0.160
 Why?
Health Services for the Aged
1
2001
72
0.160
 Why?
Short Interspersed Nucleotide Elements
1
2000
12
0.160
 Why?
Enterovirus
3
1995
83
0.160
 Why?
Laboratories
1
2001
110
0.160
 Why?
HIV-1
5
2018
905
0.160
 Why?
Feces
3
2017
514
0.160
 Why?
Acquired Immunodeficiency Syndrome
2
1993
237
0.150
 Why?
Antidepressive Agents
2
2013
250
0.150
 Why?
Carrier Proteins
2
2001
733
0.150
 Why?
Cohort Studies
10
2022
5992
0.150
 Why?
Immunoenzyme Techniques
3
2006
199
0.150
 Why?
Retroelements
1
2000
51
0.150
 Why?
Leukocytes, Mononuclear
5
2010
573
0.150
 Why?
Epitope Mapping
3
2005
61
0.150
 Why?
Immunization, Passive
4
1994
90
0.150
 Why?
Base Sequence
10
2007
2180
0.150
 Why?
Dietary Supplements
1
2024
580
0.150
 Why?
Antibodies, Monoclonal, Humanized
1
2026
994
0.150
 Why?
Myocytes, Cardiac
1
2004
544
0.150
 Why?
Immunization Schedule
3
2016
186
0.150
 Why?
Pneumococcal Infections
2
2013
103
0.150
 Why?
Hemophilia A
2
1993
147
0.150
 Why?
Delivery of Health Care, Integrated
1
2022
299
0.140
 Why?
Heart Transplantation
2
2007
676
0.140
 Why?
Myocardium
3
2001
932
0.140
 Why?
Cholera Toxin
1
2018
29
0.140
 Why?
Autophagosomes
1
2018
20
0.140
 Why?
Liver Transplantation
1
2006
831
0.140
 Why?
Infant, Premature, Diseases
3
1995
113
0.140
 Why?
Microbial Sensitivity Tests
8
2005
378
0.140
 Why?
Age Distribution
3
2016
403
0.140
 Why?
Lymphocytes
8
1998
379
0.140
 Why?
Sex Distribution
3
2016
387
0.140
 Why?
Killer Cells, Natural
2
2025
480
0.140
 Why?
Fatty Acid-Binding Proteins
1
2018
79
0.130
 Why?
Drug Therapy, Combination
4
2016
1046
0.130
 Why?
Regression Analysis
2
2019
1001
0.130
 Why?
Immune Evasion
1
2018
62
0.130
 Why?
Viral Fusion Proteins
1
2017
21
0.130
 Why?
Simian virus 40
11
1977
24
0.130
 Why?
Lysosomes
1
2018
128
0.130
 Why?
Genes, Viral
2
2006
89
0.130
 Why?
Clinical Trials, Phase II as Topic
1
2017
76
0.130
 Why?
Multivariate Analysis
2
2018
1544
0.130
 Why?
Clinical Trials, Phase I as Topic
1
2017
50
0.130
 Why?
Protein Subunits
1
2018
228
0.130
 Why?
Hepatitis B Vaccines
2
2026
43
0.130
 Why?
Lysosomal-Associated Membrane Protein 1
1
2017
12
0.130
 Why?
Cell Division
5
2003
753
0.130
 Why?
Disease Transmission, Infectious
1
2018
69
0.130
 Why?
Cryopreservation
1
2018
109
0.130
 Why?
Cost of Illness
5
2014
324
0.130
 Why?
Observational Studies as Topic
1
2017
133
0.130
 Why?
Body Mass Index
1
2026
2425
0.130
 Why?
Models, Biological
1
2005
1815
0.130
 Why?
Infectious Mononucleosis
2
1991
10
0.120
 Why?
Adverse Drug Reaction Reporting Systems
1
2017
82
0.120
 Why?
Receptors, Muscarinic
1
1996
20
0.120
 Why?
Receptors, Adrenergic, beta-2
1
1996
36
0.120
 Why?
Africa
1
2017
119
0.120
 Why?
Infusions, Intravenous
2
2016
427
0.120
 Why?
Foscarnet
3
2003
21
0.120
 Why?
Triatoma
2
2006
7
0.120
 Why?
Nelfinavir
1
2016
8
0.120
 Why?
Latex Fixation Tests
1
1996
4
0.120
 Why?
Erythema
1
2016
28
0.120
 Why?
Comorbidity
3
2019
1659
0.120
 Why?
Depression
3
2013
1573
0.120
 Why?
Lopinavir
1
2016
30
0.120
 Why?
Atazanavir Sulfate
1
2016
42
0.120
 Why?
Insect Vectors
2
2006
39
0.120
 Why?
Ribavirin
2
1994
81
0.120
 Why?
Peptide Fragments
3
2007
693
0.120
 Why?
Autophagy
1
2018
288
0.120
 Why?
Frailty
1
2019
204
0.120
 Why?
HIV Protease Inhibitors
1
2016
69
0.120
 Why?
Ritonavir
1
2016
75
0.110
 Why?
Bone Marrow Transplantation
3
1990
297
0.110
 Why?
Dipeptides
1
2015
56
0.110
 Why?
Lymphocyte Subsets
1
2015
79
0.110
 Why?
Chronic Disease
6
2019
1816
0.110
 Why?
Drug Administration Schedule
3
2026
782
0.110
 Why?
Host-Pathogen Interactions
1
2018
369
0.110
 Why?
Genotype
3
2008
1853
0.110
 Why?
Brain Stem
1
1995
98
0.110
 Why?
BK Virus
1
2015
18
0.110
 Why?
Programmed Cell Death 1 Receptor
1
2017
264
0.110
 Why?
Data Interpretation, Statistical
3
2019
369
0.110
 Why?
Guatemala
1
2016
344
0.110
 Why?
Hospitalization
2
2023
2458
0.110
 Why?
TOR Serine-Threonine Kinases
1
2018
452
0.110
 Why?
Propylene Glycols
1
2015
28
0.110
 Why?
Hematopoietic Stem Cell Transplantation
2
2015
700
0.110
 Why?
Medication Reconciliation
1
2015
32
0.110
 Why?
Sphingosine
1
2015
45
0.110
 Why?
Global Health
1
2018
404
0.110
 Why?
Reproducibility of Results
5
2013
3424
0.110
 Why?
Transfusion Reaction
1
1995
61
0.110
 Why?
Infant, Newborn, Diseases
1
2016
115
0.110
 Why?
COS Cells
2
2007
177
0.110
 Why?
Maus Elberfeld virus
2
1991
5
0.100
 Why?
Survival Rate
3
2016
2093
0.100
 Why?
Respiratory Syncytial Viruses
4
1993
58
0.100
 Why?
Maternal-Fetal Exchange
3
1995
170
0.100
 Why?
Immunity, Mucosal
2
2012
98
0.100
 Why?
Chlamydia trachomatis
2
1991
49
0.100
 Why?
Species Specificity
3
2006
573
0.100
 Why?
Histocompatibility Antigens Class I
1
1996
203
0.100
 Why?
Hemagglutinins, Viral
1
1994
8
0.100
 Why?
Clinical Trials, Phase III as Topic
3
2021
116
0.100
 Why?
Laryngeal Diseases
1
1994
31
0.100
 Why?
DNA-Directed DNA Polymerase
2
1992
48
0.100
 Why?
Rats
4
2006
5581
0.100
 Why?
Lymphoma
1
2015
234
0.100
 Why?
Autoantigens
1
1996
426
0.100
 Why?
Zidovudine
2
2015
77
0.100
 Why?
Immunoglobulins, Intravenous
5
1995
133
0.100
 Why?
Lamivudine
2
2015
65
0.100
 Why?
Controlled Clinical Trials as Topic
1
2013
27
0.100
 Why?
Analgesics
3
2010
233
0.100
 Why?
Needs Assessment
1
2016
401
0.100
 Why?
Placenta
2
1991
784
0.100
 Why?
Cross-Over Studies
2
2013
607
0.100
 Why?
Ethics, Research
1
2013
33
0.100
 Why?
Anti-Inflammatory Agents
3
2013
478
0.100
 Why?
Research Subjects
1
2013
39
0.100
 Why?
Practice Guidelines as Topic
2
2017
1585
0.090
 Why?
Mice, Inbred BALB C
3
2006
1261
0.090
 Why?
Epitopes, T-Lymphocyte
1
2014
175
0.090
 Why?
RNA Probes
2
1991
12
0.090
 Why?
Health Status
2
2010
836
0.090
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1996
296
0.090
 Why?
Dose-Response Relationship, Drug
4
2026
2030
0.090
 Why?
Measles Vaccine
1
2012
19
0.090
 Why?
Picornaviridae Infections
2
1990
53
0.090
 Why?
Gene Expression Regulation, Viral
1
2012
94
0.090
 Why?
Autoimmune Diseases
1
1996
469
0.090
 Why?
Risk Assessment
4
2016
3759
0.090
 Why?
Human papillomavirus 31
1
2011
1
0.090
 Why?
Drug Resistance, Microbial
4
2001
71
0.090
 Why?
Immunosuppressive Agents
3
2015
842
0.090
 Why?
Ureaplasma urealyticum
1
1991
3
0.090
 Why?
Colorado
4
2018
4572
0.090
 Why?
Flow Cytometry
5
2017
1156
0.090
 Why?
Meningitis, Aseptic
1
1991
13
0.090
 Why?
T-Lymphocytes, Cytotoxic
2
2011
177
0.090
 Why?
Indoles
1
2015
508
0.090
 Why?
Linear Models
2
2010
848
0.080
 Why?
Efficiency
1
2012
104
0.080
 Why?
Chorioamnionitis
1
1991
50
0.080
 Why?
Mutation
5
2009
4093
0.080
 Why?
Gastroenteritis
2
1989
63
0.080
 Why?
Cytotoxicity Tests, Immunologic
2
1996
38
0.080
 Why?
Macrophages
3
2005
1509
0.080
 Why?
Insurance, Health
1
2014
308
0.080
 Why?
Neurogenesis
1
2012
157
0.080
 Why?
Neural Stem Cells
1
2012
168
0.080
 Why?
Sequence Alignment
2
2008
371
0.080
 Why?
Drug Design
1
2012
176
0.080
 Why?
Adjuvants, Pharmaceutic
2
2022
15
0.080
 Why?
Epidemiological Monitoring
3
2018
70
0.080
 Why?
Cervix Uteri
1
2010
50
0.080
 Why?
Exanthema
1
2011
86
0.080
 Why?
Serum
1
2010
57
0.080
 Why?
Sensitivity and Specificity
3
2009
2002
0.080
 Why?
Adenoviridae
9
2005
199
0.080
 Why?
Herpesviridae
2
1981
22
0.080
 Why?
Electrocardiography
2
2005
669
0.080
 Why?
Antidepressive Agents, Tricyclic
1
2010
31
0.080
 Why?
Herpesvirus Vaccines
1
2010
4
0.080
 Why?
Heart Rate
2
2006
859
0.080
 Why?
Antigen-Presenting Cells
5
2010
159
0.080
 Why?
Immunoglobulin M
1
1991
282
0.080
 Why?
Enterovirus B, Human
2
1988
25
0.080
 Why?
Respiratory Tract Infections
1
1994
395
0.080
 Why?
Dermatomyositis
1
1989
24
0.080
 Why?
Poliovirus
2
2001
73
0.070
 Why?
Health Services Accessibility
1
2018
1101
0.070
 Why?
DNA, Kinetoplast
2
2006
2
0.070
 Why?
Medicaid
1
2014
466
0.070
 Why?
Receptors, Virus
2
2006
96
0.070
 Why?
Placenta Diseases
1
1989
20
0.070
 Why?
DNA Primers
2
2009
507
0.070
 Why?
Protozoan Infections
1
1989
11
0.070
 Why?
Thymidine Kinase
4
2001
16
0.070
 Why?
Drug Stability
1
2009
169
0.070
 Why?
Surveys and Questionnaires
7
2021
6070
0.070
 Why?
Pilot Projects
1
2015
1896
0.070
 Why?
Skin Diseases, Viral
1
2008
6
0.070
 Why?
Oligonucleotide Probes
1
1988
48
0.070
 Why?
Geriatrics
1
2010
95
0.070
 Why?
Immunologic Deficiency Syndromes
2
1986
66
0.070
 Why?
Gene Expression
2
2006
1478
0.070
 Why?
Vagina
1
2010
203
0.070
 Why?
Muscles
1
1989
332
0.070
 Why?
Hydrocortisone
1
2010
298
0.070
 Why?
Kinetics
2
2010
1605
0.070
 Why?
In Vitro Techniques
6
2003
1047
0.070
 Why?
Administration, Intranasal
1
2008
94
0.070
 Why?
Poisson Distribution
2
2005
78
0.070
 Why?
Interferon Type I
1
1989
147
0.070
 Why?
Geriatric Assessment
1
2010
238
0.070
 Why?
Picornaviridae
1
1988
18
0.070
 Why?
Postoperative Complications
2
2000
2962
0.070
 Why?
Lipid A
2
2018
27
0.070
 Why?
Enterocolitis, Pseudomembranous
1
1988
29
0.070
 Why?
Pertussis Vaccine
1
2007
24
0.070
 Why?
Anticonvulsants
1
2010
246
0.070
 Why?
Evidence-Based Practice
1
2010
230
0.070
 Why?
Immunosorbent Techniques
1
2007
18
0.060
 Why?
Quality-Adjusted Life Years
1
2007
123
0.060
 Why?
Data Collection
1
2010
639
0.060
 Why?
Spinal Cord
2
2001
384
0.060
 Why?
Cricetulus
1
2007
115
0.060
 Why?
Receptor, IGF Type 2
1
2006
5
0.060
 Why?
Prevalence
4
2018
2855
0.060
 Why?
Acute Kidney Injury
1
2015
873
0.060
 Why?
Inhibitory Concentration 50
1
2006
90
0.060
 Why?
Vero Cells
1
2006
84
0.060
 Why?
Trypanosomatina
1
2006
1
0.060
 Why?
Opportunistic Infections
3
1993
47
0.060
 Why?
Research
1
2010
432
0.060
 Why?
Immunoglobulin Fragments
1
2006
11
0.060
 Why?
Public Health
1
2012
573
0.060
 Why?
Neutralization Tests
5
2012
76
0.060
 Why?
Animal Diseases
1
2006
9
0.060
 Why?
NIH 3T3 Cells
1
2006
147
0.060
 Why?
Administration, Topical
4
2013
153
0.060
 Why?
Cyclic AMP
1
2007
207
0.060
 Why?
Veterans
1
2018
1626
0.060
 Why?
Pregnancy Outcome
1
2010
497
0.060
 Why?
Immunoglobulin Variable Region
1
2006
80
0.060
 Why?
Meningococcal Vaccines
1
2006
57
0.060
 Why?
Random Allocation
6
1992
366
0.060
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
1996
1965
0.060
 Why?
Trees
1
2006
67
0.060
 Why?
Kaplan-Meier Estimate
3
2016
974
0.060
 Why?
Hepatitis A Vaccines
1
2026
19
0.060
 Why?
Nasopharyngeal Diseases
1
1985
5
0.060
 Why?
Hybridization, Genetic
9
1974
75
0.060
 Why?
Pneumonia, Viral
2
1990
389
0.060
 Why?
Logistic Models
2
2010
2130
0.060
 Why?
Endocytosis
1
2006
168
0.060
 Why?
Motor Activity
1
2010
723
0.060
 Why?
Bone Marrow
2
1984
307
0.060
 Why?
Sequence Analysis, DNA
3
2007
831
0.060
 Why?
GB virus C
1
2005
1
0.060
 Why?
Flaviviridae Infections
1
2005
2
0.060
 Why?
Uterine Cervical Dysplasia
2
2016
27
0.060
 Why?
Proportional Hazards Models
1
2009
1332
0.060
 Why?
Hepatitis, Viral, Human
1
2005
21
0.060
 Why?
Antineoplastic Agents
2
2016
2207
0.060
 Why?
Predictive Value of Tests
3
2010
2129
0.060
 Why?
Hydrogen-Ion Concentration
1
2006
563
0.060
 Why?
Normal Distribution
1
2005
22
0.060
 Why?
HLA Antigens
3
1987
238
0.050
 Why?
Evaluation Studies as Topic
3
1996
164
0.050
 Why?
Blotting, Western
3
2015
1162
0.050
 Why?
Cell Differentiation
1
2012
2045
0.050
 Why?
Transfection
1
2007
925
0.050
 Why?
Organ Transplantation
1
2008
251
0.050
 Why?
Open Reading Frames
2
2007
131
0.050
 Why?
Conservation of Natural Resources
1
2006
133
0.050
 Why?
Autopsy
2
2001
95
0.050
 Why?
Mammals
1
2006
296
0.050
 Why?
Neurons, Afferent
1
2005
102
0.050
 Why?
Risk
3
2016
917
0.050
 Why?
Disease Outbreaks
1
1988
426
0.050
 Why?
Receptors, Cholinergic
1
2004
41
0.050
 Why?
Macaca radiata
2
2001
15
0.050
 Why?
Cell Culture Techniques
1
2006
373
0.050
 Why?
Cell Adhesion Molecules
1
2005
181
0.050
 Why?
Receptors, Adrenergic, beta
1
2004
58
0.050
 Why?
Polymorphism, Restriction Fragment Length
1
2003
63
0.050
 Why?
Sex Factors
2
2003
2110
0.050
 Why?
Mental Health
1
2010
795
0.050
 Why?
Demography
2
2018
287
0.050
 Why?
Abdominal Neoplasms
1
2003
47
0.050
 Why?
Down-Regulation
1
2025
616
0.050
 Why?
Receptors, Cell Surface
1
2005
372
0.050
 Why?
2-Aminopurine
2
2007
9
0.050
 Why?
RNA
2
1988
929
0.050
 Why?
Polymorphism, Single Nucleotide
2
2009
2146
0.050
 Why?
Adaptive Immunity
2
2017
169
0.050
 Why?
Membrane Glycoproteins
1
2005
496
0.050
 Why?
Multicenter Studies as Topic
2
2001
411
0.050
 Why?
Biopsy
2
2000
1081
0.050
 Why?
Pre-Exposure Prophylaxis
1
2026
268
0.050
 Why?
Argentina
3
2006
30
0.050
 Why?
Poliomyelitis
2
2001
35
0.050
 Why?
Dendritic Cells
1
2025
499
0.040
 Why?
Neuroblastoma
1
2003
174
0.040
 Why?
Maltose-Binding Proteins
1
2001
13
0.040
 Why?
Forecasting
3
2010
391
0.040
 Why?
Hepatitis C
1
2004
257
0.040
 Why?
Glutathione Transferase
1
2001
96
0.040
 Why?
Cell Nucleus
3
1991
593
0.040
 Why?
Respirovirus Infections
2
1991
14
0.040
 Why?
Spondylarthropathies
1
2021
5
0.040
 Why?
Poliovirus Vaccine, Oral
1
2001
25
0.040
 Why?
Interspersed Repetitive Sequences
1
2000
5
0.040
 Why?
Peripheral Nerves
1
2001
72
0.040
 Why?
Blotting, Southern
1
2000
84
0.040
 Why?
Expressed Sequence Tags
1
2000
43
0.040
 Why?
Fatal Outcome
1
2001
306
0.040
 Why?
Endocardium
1
2000
32
0.040
 Why?
Alanine
1
2001
170
0.040
 Why?
Mutagenesis
1
2001
194
0.040
 Why?
Cloning, Molecular
1
2001
535
0.040
 Why?
Blotting, Northern
1
2000
203
0.040
 Why?
Secondary Prevention
2
2013
256
0.040
 Why?
Phosphorylation
2
2002
1707
0.040
 Why?
Genome, Viral
1
2002
218
0.040
 Why?
Virion
1
2001
111
0.040
 Why?
Sex Characteristics
2
2017
779
0.040
 Why?
Amino Acid Motifs
1
2000
220
0.040
 Why?
DNA, Protozoan
1
2000
32
0.040
 Why?
Consensus Sequence
1
2000
73
0.040
 Why?
DEAD-box RNA Helicases
1
2000
89
0.040
 Why?
Canada
2
2012
434
0.040
 Why?
Psoriasis
1
2021
115
0.040
 Why?
Amniotic Fluid
3
1991
79
0.040
 Why?
Immunity, Innate
1
2025
846
0.040
 Why?
Chromosome Mapping
1
2000
509
0.040
 Why?
Transcription, Genetic
5
2000
1468
0.040
 Why?
Sequence Homology, Amino Acid
1
2000
393
0.040
 Why?
Autoimmunity
1
2005
936
0.040
 Why?
Enterotoxins
2
1994
89
0.040
 Why?
Sleep
1
2006
891
0.040
 Why?
Recombinant Fusion Proteins
1
2001
667
0.040
 Why?
Rats, Sprague-Dawley
1
2004
2526
0.030
 Why?
Saponins
1
2018
12
0.030
 Why?
Hematopoietic Stem Cells
1
1982
419
0.030
 Why?
Seroconversion
1
2018
48
0.030
 Why?
Saliva
2
2010
247
0.030
 Why?
Encephalitis, Viral
1
1998
45
0.030
 Why?
Haptoglobins
1
2018
71
0.030
 Why?
Drug Compounding
1
2018
107
0.030
 Why?
Protein Precursors
1
2018
136
0.030
 Why?
Immunologic Techniques
2
1994
38
0.030
 Why?
Celiac Disease
1
2021
310
0.030
 Why?
Glucosides
1
2017
55
0.030
 Why?
Inositol Phosphates
1
2017
21
0.030
 Why?
Sterols
1
2017
20
0.030
 Why?
Botswana
1
2017
11
0.030
 Why?
Cell Transformation, Neoplastic
5
1977
337
0.030
 Why?
Health Surveys
1
2019
518
0.030
 Why?
International Cooperation
1
2018
197
0.030
 Why?
Internationality
1
2018
156
0.030
 Why?
Chemotaxis
1
2017
123
0.030
 Why?
Graft Rejection
1
2000
519
0.030
 Why?
Zimbabwe
1
2017
76
0.030
 Why?
Zambia
1
2017
58
0.030
 Why?
Bisoprolol
1
1996
2
0.030
 Why?
Tanzania
1
2017
72
0.030
 Why?
Antigens, Bacterial
1
2017
128
0.030
 Why?
Plasma
1
2018
225
0.030
 Why?
Patient Safety
1
2020
357
0.030
 Why?
Propanolamines
1
1996
40
0.030
 Why?
Cerebrospinal Fluid
2
1993
88
0.030
 Why?
Recovery of Function
1
2021
716
0.030
 Why?
Sinusitis
1
1999
227
0.030
 Why?
Acute Disease
2
2011
1040
0.030
 Why?
Leukemia, Lymphoid
2
1986
27
0.030
 Why?
Biomarkers
2
2018
4283
0.030
 Why?
Immune Tolerance
4
1998
384
0.030
 Why?
False Negative Reactions
1
1996
61
0.030
 Why?
Public Health Surveillance
1
2016
83
0.030
 Why?
False Positive Reactions
1
1996
123
0.030
 Why?
Amniocentesis
2
1991
20
0.030
 Why?
Inhibitor of Apoptosis Proteins
1
2015
45
0.030
 Why?
Analysis of Variance
2
2011
1304
0.030
 Why?
AIDS Dementia Complex
1
2015
52
0.030
 Why?
Nevirapine
1
2015
18
0.030
 Why?
Half-Life
2
1992
153
0.030
 Why?
Depressive Disorder
1
1998
387
0.030
 Why?
Adrenergic beta-Antagonists
1
1996
252
0.030
 Why?
Cross-Sectional Studies
4
2011
5891
0.030
 Why?
Chi-Square Distribution
2
2013
529
0.030
 Why?
Nausea
1
2015
113
0.030
 Why?
Area Under Curve
1
2015
329
0.030
 Why?
Vomiting
1
2015
132
0.030
 Why?
Bromodeoxyuridine
2
2007
77
0.030
 Why?
Fingolimod Hydrochloride
1
2015
39
0.030
 Why?
Disease Susceptibility
1
1996
343
0.030
 Why?
Gene Regulatory Networks
1
2017
320
0.030
 Why?
Product Surveillance, Postmarketing
1
2015
74
0.030
 Why?
Breast Feeding
1
2018
447
0.030
 Why?
Belgium
1
2014
11
0.030
 Why?
Neutropenia
1
2015
155
0.030
 Why?
Headache
1
2015
151
0.030
 Why?
Vaccines, Virus-Like Particle
1
2014
5
0.030
 Why?
HLA-A2 Antigen
1
2014
36
0.030
 Why?
Metabolic Diseases
1
2015
114
0.030
 Why?
Rubella
1
1974
23
0.030
 Why?
Culture Media
2
1984
163
0.030
 Why?
Immunoblotting
1
1994
294
0.030
 Why?
Tetanus Toxoid
1
1994
34
0.030
 Why?
Probability
2
2005
310
0.030
 Why?
Drugs, Investigational
1
2014
31
0.030
 Why?
Hemagglutinin Glycoproteins, Influenza Virus
1
1994
29
0.030
 Why?
Bacterial Proteins
1
2000
991
0.030
 Why?
Seroepidemiologic Studies
1
2014
171
0.020
 Why?
Statistics, Nonparametric
2
2004
432
0.020
 Why?
Anemia
1
2015
190
0.020
 Why?
Phenotype
1
2002
3157
0.020
 Why?
Thrombocytopenia
1
2015
203
0.020
 Why?
Developed Countries
1
2013
38
0.020
 Why?
Haplorhini
8
1974
52
0.020
 Why?
Mortality
1
2015
379
0.020
 Why?
Drug Tolerance
1
1992
99
0.020
 Why?
Human papillomavirus 6
1
2011
2
0.020
 Why?
Ureaplasma Infections
1
1991
3
0.020
 Why?
Mycoplasma Infections
1
1991
17
0.020
 Why?
Arthritis, Rheumatoid
1
2021
1177
0.020
 Why?
Genetics, Microbial
3
1971
11
0.020
 Why?
Safety
1
1994
357
0.020
 Why?
Skin
2
1989
766
0.020
 Why?
Genitalia, Female
1
2012
42
0.020
 Why?
gamma-Globulins
1
1991
14
0.020
 Why?
Antibodies, Heterophile
1
1991
12
0.020
 Why?
Epstein-Barr Virus Nuclear Antigens
1
1991
12
0.020
 Why?
Adrenal Cortex Hormones
1
2015
482
0.020
 Why?
Phylogeny
2
2006
1028
0.020
 Why?
Absenteeism
1
2012
52
0.020
 Why?
Adenoviruses, Human
1
1991
26
0.020
 Why?
Metabolomics
1
2017
729
0.020
 Why?
Hospitals, University
1
1991
176
0.020
 Why?
Matched-Pair Analysis
1
2011
37
0.020
 Why?
Bodily Secretions
1
2010
2
0.020
 Why?
Paramyxoviridae Infections
1
1990
12
0.020
 Why?
North America
1
2012
312
0.020
 Why?
Tritium
7
1974
68
0.020
 Why?
Diagnosis, Differential
3
2009
1507
0.020
 Why?
Early Detection of Cancer
1
2016
482
0.020
 Why?
Europe
1
2012
421
0.020
 Why?
Inflammation
2
2017
2883
0.020
 Why?
Chlamydia Infections
1
1991
79
0.020
 Why?
Schwann Cells
1
1990
33
0.020
 Why?
Bacterial Infections
2
2001
247
0.020
 Why?
DNA
4
1988
1451
0.020
 Why?
Antigens
2
1970
349
0.020
 Why?
Cell Proliferation
1
2018
2499
0.020
 Why?
Rhinovirus
1
1990
60
0.020
 Why?
Antigens, Surface
2
1987
155
0.020
 Why?
Serotyping
2
1988
32
0.020
 Why?
Health Planning Guidelines
1
2010
24
0.020
 Why?
Self Administration
1
2010
124
0.020
 Why?
Gene Expression Profiling
1
2017
1769
0.020
 Why?
Hepatitis B Antibodies
1
2009
6
0.020
 Why?
Drug Resistance, Neoplasm
1
2015
881
0.020
 Why?
Gestational Age
2
1989
988
0.020
 Why?
beta-Globins
1
2009
8
0.020
 Why?
In Situ Hybridization
2
2001
318
0.020
 Why?
Contraceptive Devices, Male
1
1989
1
0.020
 Why?
Spermatocidal Agents
1
1989
6
0.020
 Why?
Subacute Sclerosing Panencephalitis
1
1989
6
0.020
 Why?
Ribonucleosides
1
1989
7
0.020
 Why?
Immunohistochemistry
1
1993
1710
0.020
 Why?
Prenatal Exposure Delayed Effects
1
2016
651
0.020
 Why?
Reference Values
1
2011
797
0.020
 Why?
Physical Examination
1
2010
243
0.020
 Why?
Thymidine
4
1980
60
0.020
 Why?
RNA, Antisense
1
1988
18
0.020
 Why?
Reference Standards
1
2009
178
0.020
 Why?
Nasal Mucosa
1
2009
112
0.020
 Why?
Virus Cultivation
4
1984
31
0.020
 Why?
Astrocytes
1
1990
230
0.020
 Why?
Reoviridae
1
1988
38
0.020
 Why?
Measles
1
1989
46
0.020
 Why?
Mammalian orthoreovirus 3
1
1988
38
0.020
 Why?
Hepatitis
1
1988
43
0.020
 Why?
Disease Progression
1
2016
2862
0.020
 Why?
DNA, Recombinant
1
1988
48
0.020
 Why?
Cancer Vaccines
1
2009
161
0.020
 Why?
Reoviridae Infections
1
1988
55
0.020
 Why?
Neoplasms, Experimental
1
1969
168
0.020
 Why?
Fetus
1
1992
804
0.020
 Why?
Sequence Homology, Nucleic Acid
1
1988
156
0.020
 Why?
Health Services Needs and Demand
1
2010
279
0.020
 Why?
Cytopathogenic Effect, Viral
2
1982
16
0.020
 Why?
Microscopy, Electron
3
2001
413
0.020
 Why?
Body Fluids
1
1987
71
0.020
 Why?
Australia
1
2008
289
0.020
 Why?
Noma
1
1986
2
0.020
 Why?
Heptavalent Pneumococcal Conjugate Vaccine
1
2006
13
0.020
 Why?
Apoptosis
1
2015
2411
0.020
 Why?
Biliary Atresia
1
1988
158
0.020
 Why?
Xenodiagnosis
1
2006
2
0.020
 Why?
Telomere
1
2010
290
0.020
 Why?
Valine
1
2007
82
0.020
 Why?
Gastrointestinal Hemorrhage
1
1988
138
0.020
 Why?
Embryo, Mammalian
3
1973
234
0.010
 Why?
Interleukin-4
2
1998
208
0.010
 Why?
Amino Acid Substitution
1
2007
303
0.010
 Why?
Kidney
9
1975
1498
0.010
 Why?
RNA, Ribosomal
1
2006
170
0.010
 Why?
Statistics as Topic
1
2006
284
0.010
 Why?
Reagent Kits, Diagnostic
1
1985
34
0.010
 Why?
Ketones
1
1986
53
0.010
 Why?
Nectins
1
2005
7
0.010
 Why?
Gene Amplification
1
2006
120
0.010
 Why?
Anti-Bacterial Agents
2
1999
1953
0.010
 Why?
Residence Characteristics
1
2008
376
0.010
 Why?
Lymphoproliferative Disorders
1
1985
57
0.010
 Why?
Mass Screening
1
2014
1358
0.010
 Why?
Factor Analysis, Statistical
1
2006
290
0.010
 Why?
Carbon Isotopes
5
1973
144
0.010
 Why?
Streptococcus pneumoniae
1
2006
180
0.010
 Why?
Chromosomes, Human
1
1984
41
0.010
 Why?
Toll-Like Receptor 2
1
2005
127
0.010
 Why?
California
1
2006
483
0.010
 Why?
Cytotoxicity, Immunologic
1
1985
226
0.010
 Why?
Hexuronic Acids
1
1984
29
0.010
 Why?
Glucuronic Acid
1
1984
30
0.010
 Why?
Toll-Like Receptors
1
2005
193
0.010
 Why?
Intensive Care Units, Neonatal
1
1988
291
0.010
 Why?
Alginates
1
1984
60
0.010
 Why?
Freezing
1
1984
86
0.010
 Why?
Polyethylene Glycols
1
1989
652
0.010
 Why?
Filtration
1
1984
71
0.010
 Why?
Culture Techniques
4
1973
66
0.010
 Why?
Bone Marrow Cells
1
1984
321
0.010
 Why?
RNA, Small Interfering
1
2005
632
0.010
 Why?
Fetal Blood
1
1985
325
0.010
 Why?
Stomatitis, Herpetic
1
1982
5
0.010
 Why?
Socioeconomic Factors
1
2007
1327
0.010
 Why?
Phosphonoacetic Acid
1
1982
10
0.010
 Why?
Up-Regulation
1
2005
848
0.010
 Why?
Agammaglobulinemia
1
1982
37
0.010
 Why?
NF-kappa B
1
2005
660
0.010
 Why?
Isoelectric Focusing
1
2001
30
0.010
 Why?
Prognosis
1
2010
4323
0.010
 Why?
Ulnar Nerve
1
2001
17
0.010
 Why?
Interleukin-6
1
2005
772
0.010
 Why?
Rural Population
1
2006
658
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
2001
325
0.010
 Why?
Temperature
1
1984
681
0.010
 Why?
Cell Survival
1
1984
1094
0.010
 Why?
Brain
1
1993
2944
0.010
 Why?
Administration, Oral
2
1997
863
0.010
 Why?
Phytohemagglutinins
1
1980
29
0.010
 Why?
Serum Albumin
1
2001
144
0.010
 Why?
Disease Models, Animal
1
1991
4559
0.010
 Why?
Neuroglia
1
2001
173
0.010
 Why?
Phagocytosis
1
1982
297
0.010
 Why?
Cell Communication
1
1982
326
0.010
 Why?
Ribosomes
1
2001
196
0.010
 Why?
Leukocytes
1
1981
295
0.010
 Why?
Air Microbiology
1
1980
50
0.010
 Why?
Ambulatory Care
1
2004
608
0.010
 Why?
Nasal Decongestants
1
1999
9
0.010
 Why?
Immunity, Maternally-Acquired
1
1979
19
0.010
 Why?
Otorhinolaryngologic Surgical Procedures
1
1999
38
0.010
 Why?
Immunoglobulins
1
1979
162
0.010
 Why?
Mitogens
1
1978
55
0.010
 Why?
Lectins
1
1978
45
0.010
 Why?
Steroids
1
1999
160
0.010
 Why?
Rabbits
1
1979
651
0.010
 Why?
Th2 Cells
1
1998
175
0.010
 Why?
Amanitins
1
1977
4
0.010
 Why?
Bronchopulmonary Dysplasia
2
1993
411
0.010
 Why?
Cross Infection
1
1980
264
0.010
 Why?
Centrifugation, Density Gradient
3
1971
36
0.010
 Why?
Antigen-Antibody Complex
1
1997
70
0.010
 Why?
Interleukin-10
1
1998
313
0.010
 Why?
Combined Modality Therapy
1
1999
1269
0.010
 Why?
Erythrocytes
1
1982
751
0.010
 Why?
Adenoviridae Infections
1
1975
20
0.010
 Why?
Evidence-Based Medicine
1
1999
738
0.010
 Why?
Indicator Dilution Techniques
1
1994
12
0.010
 Why?
Uridine
2
1973
30
0.010
 Why?
Patient Selection
1
1999
742
0.010
 Why?
Centrifugation, Zonal
2
1971
2
0.010
 Why?
Abortion, Therapeutic
1
1974
3
0.010
 Why?
Rubella virus
1
1974
7
0.010
 Why?
Cesium
2
1971
20
0.010
 Why?
Heart Defects, Congenital
2
1993
909
0.010
 Why?
Molecular Biology
2
1971
57
0.010
 Why?
Sucrose
2
1971
115
0.010
 Why?
Chlorides
2
1971
142
0.010
 Why?
Complement Fixation Tests
2
1984
5
0.010
 Why?
Hemagglutination Tests
1
1991
7
0.010
 Why?
Pulmonary Fibrosis
1
1975
393
0.010
 Why?
Genes
1
1971
226
0.010
 Why?
Stress, Psychological
1
1998
1153
0.000
 Why?
Population Surveillance
1
1993
485
0.000
 Why?
Nonoxynol
1
1989
4
0.000
 Why?
Latex
1
1989
9
0.000
 Why?
Kidney Transplantation
1
1975
711
0.000
 Why?
Suspensions
1
1987
28
0.000
 Why?
Ribonucleases
1
1987
49
0.000
 Why?
Chloroquine
1
1987
54
0.000
 Why?
Deltaretrovirus
1
1986
12
0.000
 Why?
Binding, Competitive
1
1985
182
0.000
 Why?
Leukocyte Count
1
1985
316
0.000
 Why?
Mitosis
1
1985
200
0.000
 Why?
Histocompatibility Antigens Class II
1
1985
365
0.000
 Why?
Serologic Tests
1
1983
54
0.000
 Why?
Histocompatibility Antigens
2
1974
102
0.000
 Why?
Infusions, Parenteral
1
1982
47
0.000
 Why?
Leukemia
1
1983
246
0.000
 Why?
Hospital Bed Capacity, 300 to 499
1
1980
3
0.000
 Why?
Air Movements
1
1980
10
0.000
 Why?
Hospital Units
1
1980
32
0.000
 Why?
Boston
1
1980
93
0.000
 Why?
Liver
1
1988
1895
0.000
 Why?
Communicable Disease Control
1
1980
86
0.000
 Why?
Methods
1
1978
68
0.000
 Why?
p-Fluorophenylalanine
1
1976
2
0.000
 Why?
Cycloheximide
1
1976
42
0.000
 Why?
Hospitals, Pediatric
1
1980
557
0.000
 Why?
Inclusion Bodies, Viral
1
1975
3
0.000
 Why?
Cytoplasm
1
1976
257
0.000
 Why?
Cadaver
1
1975
309
0.000
 Why?
Transplantation, Homologous
1
1975
420
0.000
 Why?
Genetic Code
1
1971
25
0.000
 Why?
Nucleic Acid Denaturation
1
1971
32
0.000
 Why?
Chymotrypsin
1
1971
23
0.000
 Why?
Platinum
1
1971
50
0.000
 Why?
Molecular Weight
1
1971
312
0.000
 Why?
Carbon
1
1971
204
0.000
 Why?
DNA Replication
1
1971
252
0.000
 Why?
Hot Temperature
1
1971
411
0.000
 Why?
Lung
1
1975
4103
0.000
 Why?
Levin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (855) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)